French Take Ultraconservative Stand on Biogenerics
Feb. 19, 2007
A new law expected to be passed next month in France will prevent biosimilar medicines from being classified as generics. Read this update from InPharma Technologist.
A new law expected to be passed next month in France will prevent biosimilar medicines from being classified as generics. Read this update from InPharma Technologist.
